Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Health Disparities Subcommittee (HDS), 76046 [2012-31008]
Download as PDF
<![CDATA[
76046
Federal Register / Vol. 77, No. 247 / Wednesday, December 26, 2012 / Notices
resistance and quantify HIV subtypes
among persons infected with HIV and to
monitor and evaluate perinatal HIV
prevention efforts. Health departments
funded for these supplemental data
collections obtain this information from
laboratories, health care providers, and
medical records. CDC estimates that 25
health departments will be reporting
data elements containing HIV Incidence
Surveillance (HIS) data, 53 health
departments will report additional data
elements on HIV nucleotide sequences
as part of MHS, and 35 areas will be
reporting data as part of PHER annually.
The total estimated annual burden
hours are 53,700.
Estimated Annualized Burden Hours
EXHIBIT 12.A ESTIMATES OF ANNUALIZED BURDEN HOURS
Form name
Health Departments ........................................
Health ..............................................................
Departments ....................................................
Health Departments ........................................
Health Departments ........................................
Health Departments ........................................
Health Departments ........................................
Health Departments ........................................
Kimberly S. Lane,
Deputy Director, Office of Scientific Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–31010 Filed 12–21–12; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
tkelley on DSK3SPTVN1PROD with
Number of responses per
respondent
59
1,260
20/60
59
6
20/60
59
127
20/60
59
59
1,469
5,876
2/60
1/60
25
2,729
10/60
53
35
967
114
5/60
30/60
Adult ...............................................................
HIV Case Report ............................................
Pediatric ..........................................................
HIV Case Report ............................................
Case Report ...................................................
Evaluations .....................................................
Case Report Updates .....................................
Laboratory ......................................................
Updates ..........................................................
HIV ..................................................................
Incidence Surveillance (HIS) ..........................
Molecular HIV Surveillance (MHS) .................
Perinatal HIV Exposure Reporting (PHER) ....
Health Departments ........................................
Time and Date: 3:00 p.m.—4:10 p.m., EDT,
January 23, 2013.
Place: Teleconference.
Status: Open to the public, limited only by
the availability of telephone ports. The
public is welcome to participate during the
public comment period. A public comment
period is tentatively scheduled from 4:00
p.m. to 4:05 p.m. To participate in the
teleconference, please dial (877) 953–5019
and enter code 5280655.
Purpose: The subcommittee will provide
advice to the CDC Director through the ACD
on strategic and other broad issues facing
CDC.
Matters To Be Discussed: Agenda items
will include the following: review of draft
recommendations for health equity at CDC.
VerDate Mar<15>2010
06:31 Dec 22, 2012
Jkt 229001
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, HDS, ACD,
CDC, 1600 Clifton Road NE., M/S E–67,
Atlanta, Georgia 30333, telephone (404)
498–2320, email: LEL1@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: December 18, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–31008 Filed 12–21–12; 4:15 pm]
BILLING CODE 4163–18–P
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Average Burden per response
(in hours)
Number of respondents
Type of respondent
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0176]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Experimental
Study: Examination of Corrective
Direct-to-Consumer Television
Advertising
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by January 25,
2013.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910-New and
title, ‘‘Experimental Study: Examination
of Corrective Direct-to-Consumer
Television Advertising.’’ Also include
SUMMARY:
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 77, Number 247 (Wednesday, December 26, 2012)]
[Notices]
[Page 76046]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-31008]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)--Health Disparities Subcommittee (HDS)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 3:00 p.m.--4:10 p.m., EDT, January 23, 2013.
Place: Teleconference.
Status: Open to the public, limited only by the availability of
telephone ports. The public is welcome to participate during the
public comment period. A public comment period is tentatively
scheduled from 4:00 p.m. to 4:05 p.m. To participate in the
teleconference, please dial (877) 953-5019 and enter code 5280655.
Purpose: The subcommittee will provide advice to the CDC
Director through the ACD on strategic and other broad issues facing
CDC.
Matters To Be Discussed: Agenda items will include the
following: review of draft recommendations for health equity at CDC.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Leandris Liburd, Ph.D.,
M.P.H., M.A., Designated Federal Officer, HDS, ACD, CDC, 1600 Clifton
Road NE., M/S E-67, Atlanta, Georgia 30333, telephone (404) 498-2320,
email: LEL1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: December 18, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-31008 Filed 12-21-12; 4:15 pm]
BILLING CODE 4163-18-P
